A deep learning model for multiclass lung cancer classification using multimodal data fusion

基于多模态数据融合的深度学习肺癌多类别分类模型

阅读:3

Abstract

INTRODUCTION: Lung cancer is the most prevalent malignant tumour in terms of morbidity and mortality. Accurate classification and risk staging are essential for developing appropriate treatment plans and achieving precision in lung cancer diagnosis and treatment. METHOD: A lung cancer pathological image classification model was trained using ResNet152. The image input structure of ResNet152 was modified to support custom input image block sizes. A multimodal deep learning model (MMLM) was developed that integrated features extracted from the trained ResNet152 (RNet), standardized RNA sequencing data, methylation microarray data, and clinical information through a feature-level fusion method. This process emulates the way in which pathologists integrate multimodal information to make decisions. The incorporation of Class Activation Mapping (CAM) and UMAP mapping enhanced the interpretability of the model, thus increasing its transparency and fostering greater trust in its decision-making process. RESULTS: In the context of lung cancer classification on an independent test set, compared with monomodality RNet, the MMLM demonstrated superior performance. The areas under the curve (AUC) values of the MMLM were 0.999, 1.000, and 0.980, which significantly surpassed RNet’s values of 0.822, 0.732, and 0.781, respectively. Similarly, the average precision (AP) values of the MMLM were 0.999, 1.000, and 0.909, which surpassed those of RNet (0.793, 0.606, and 0.471). In addition, supplementary validation of the ability of the MMLM to predict lung cancer risk staging yielded encouraging results. CONCLUSIONS: The MMLM integrates pathological images, RNA sequencing data, methylation data, and clinical information to improve lung cancer classification and prognosis. However, challenges remain, such as limited access to comprehensive clinical data, patient privacy concerns, and computational resource demands. The MMLM holds significant potential to become a powerful tool for personalized lung cancer diagnosis and treatment with continued advancements in data integration and privacy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-025-04168-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。